Related Experiment Videos
Virus infection and dilated cardiomyopathy
P J Richardson1, H J Why, L C Archard
1Cardiac Department, King's College Hospital, London, UK.
Insights
Virus infection, specifically enteroviruses, plays a role in dilated cardiomyopathy. Detecting enteroviral RNA in heart biopsies indicates a poor prognosis, but its clearance may signal improvement.
Area of Science:
- Cardiology
- Virology
- Pathogenesis
Background:
- Virus infection is increasingly implicated in dilated cardiomyopathy (DCM) development.
- Progression from myocarditis to DCM suggests a viral etiology.
- Histological diagnosis via endomyocardial biopsy is crucial for DCM diagnosis.
Purpose of the Study:
- To investigate the role of enteroviral RNA in dilated cardiomyopathy pathogenesis.
- To assess the prognostic value of enteroviral RNA detection in endomyocardial biopsies.
- To explore the potential impact of antiviral therapies on DCM progression.
Main Methods:
- Utilized enterovirus group-specific hybridization probes and polymerase chain reaction (PCR).
- Analyzed endomyocardial biopsy samples for the presence of enteroviral RNA.
- Correlated viral RNA detection with disease stage and patient prognosis.
Main Results:
- Enteroviral RNA sequences were detected in endomyocardial biopsies from DCM patients across all disease stages.
- Persistence of enteroviral RNA in the myocardium is associated with an adverse prognosis.
- Preliminary findings suggest viral clearance may correlate with clinical improvement.
Conclusions:
- Enteroviral RNA detection in endomyocardial biopsies is a significant prognostic marker for dilated cardiomyopathy.
- The persistence of enteroviruses in the heart may drive DCM pathogenesis.
- Future antiviral treatments hold promise for altering the natural history of enterovirus-induced DCM.
Abstract:
The implication of virus infection in the pathogenesis of dilated cardiomyopathy has been strengthened by a number of studies demonstrating a progression from myocarditis to this condition. In this context a histological diagnosis from endomyocardial biopsy is mandatory. Serological studies have provided only circumstantial evidence. The development and clinical application of enterovirus group-specific hybridization probes and the polymerase chain reaction has allowed the detection of enteroviral RNA sequences in endomyocardial biopsy samples from patients in all stages of the disease. The persistence of enteroviral RNA within the myocardium of patients with dilated cardiomyopathy appears to indicate an adverse prognosis for the patient. Preliminary data, however, suggest that disappearance of the virus may be associated with clinical improvement, offering the hope that future antiviral agents may alter the natural history of the disease.